The global brain disease modalities and software market size was valued at USD 14,355.56 million in 2024 and is projected to grow from USD 15,201.11 million in 2025 to reach USD 21,964.80 million by ...
Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...
Stimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with ...
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI ...
WHIPPANY, NJ, USA I January 14, 2025 I On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in ...